Abstract |
Since a striking association between hepatitis C virus (HCV) infection and mixed cryoglobulinemia has been demonstrated, the aim of this study is to investigate the effect of alpha-interferon (alpha-IFN) on HCV viraemia and clinico-serological manifestations of 15 patients (ten female and five male, mean [+/- SD] age 53 +/- 7 years). In 14/15 patients pre-study steroid dosage remained unchanged during treatment. alpha-IFN was administered at a dose of 2 x 10(6) IU daily for a month, then every other day for five months. On the whole, a statistically significant improvement of purpura (p < 0.001), serum transaminases (p < 0.001), and cryocrit (p < 0.01) was observed after alpha-IFN treatment. HCV viraemia was detected by polymerase chain reaction technique in 13/15 patients with mixed cryoglobulinemia and anti-GOR antibodies, expression of HCV-related autoimmunity, were present in 8/15. After alpha-IFN treatment, HCV RNA levels showed a clear-cut reduction in five persons and disappeared in another, while anti-HCV antibodies ( Chiron ELISA and RIBA II) did not change after the six-month period of therapy. These data further support the possible etiopathogenetic role of HCV in patients with mixed cryoglobulinemia and suggest that alpha-IFN may be regarded as the elective treatment in this disease.
|
Authors | C Ferri, A L Zignego, G Longombardo, M Monti, L La Civita, F Lombardini, F Greco, A Mazzoni, G Pasero, P Gentilini |
Journal | Infection
(Infection)
1993 Mar-Apr
Vol. 21
Issue 2
Pg. 93-7
ISSN: 0300-8126 [Print] Germany |
PMID | 7684029
(Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hepatitis Antibodies
- Hepatitis C Antibodies
- Interferon-alpha
|
Topics |
- Chronic Disease
- Cryoglobulinemia
(complications, immunology)
- Drug Administration Schedule
- Female
- Hepacivirus
(immunology, isolation & purification)
- Hepatitis Antibodies
(isolation & purification)
- Hepatitis C
(drug therapy, immunology)
- Hepatitis C Antibodies
- Humans
- Interferon-alpha
(pharmacology)
- Male
- Middle Aged
- Viremia
(drug therapy, immunology)
|